Edge
StocktwitsEarnings

Official STOCKTWITS Representative

$ANIK Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of $0.25 up 189.29% YoY
• Reported revenue of $32.61M up 15.56% YoY
• Anika Therapeutics, Inc. is raising its full-year 2026 revenue growth guidance to 5% to 10% and its adjusted EBITDA margin outlook to 13% to 17% for the fiscal year.Price since post
Advertisement|Remove ads.